Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Revvity Omics, |
RCV003147196 | SCV003833962 | uncertain significance | not provided | 2021-08-16 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004246142 | SCV004869780 | uncertain significance | Inborn genetic diseases | 2023-10-25 | criteria provided, single submitter | clinical testing | The c.4721C>T (p.T1574I) alteration is located in exon 1 (coding exon 1) of the FAT4 gene. This alteration results from a C to T substitution at nucleotide position 4721, causing the threonine (T) at amino acid position 1574 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Fulgent Genetics, |
RCV005029922 | SCV005662281 | uncertain significance | Van Maldergem syndrome 2; Hennekam lymphangiectasia-lymphedema syndrome 2 | 2024-03-01 | criteria provided, single submitter | clinical testing |